Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.

Richard Chen, PA

Clinical Instructor

About

Titles

Staff Affiliate in Emergency Medicine

Departments & Organizations

Yale New Haven Health System

Education & Training

PA: Yale University Physician Associate Program (2007)

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Richard Chen's published research.

Ian Krop, MD, PhD
View Full Profile
View Common Publication

Publications

2026

Xiangshao granules regulate the dopaminergic synapse pathway and improve menopausal anxiety in peri- and postmenopausal Chinese women: A multi-center, double-blind, randomized controlled trial
Tang R, Xie Z, Fan Y, Zhang J, Lu L, Zhuang Y, Guo C, Shu K, Li S, Zhang P, Liu K, Zhang Y, Ji J, Ren Q, Meng Q, Lin Y, Huang X, Li H, Liu Y, Deng Q, Chen H, Su M, Zhang X, Wang Y, Liang Y, Zhang P, Chen R. Xiangshao granules regulate the dopaminergic synapse pathway and improve menopausal anxiety in peri- and postmenopausal Chinese women: A multi-center, double-blind, randomized controlled trial. Acta Pharmaceutica Sinica B 2026, 16: 5847-5863. DOI: 10.1016/j.apsb.2026.06.024.
Peer-Reviewed Original Research
Circulating tumor DNA dynamics in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer assessed using an ultrasensitive tumor-informed assay ☆
Barcenas C, Contreras A, Alexander A, Lopez H, Yu R, Shete S, Chen Y, Abbott C, Keough K, Boyle S, Chen R, Tripathy D, Valero V. Circulating tumor DNA dynamics in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer assessed using an ultrasensitive tumor-informed assay ☆. ESMO Open 2026, 11: 108360. PMID: 42617422, PMCID: PMC13520885, DOI: 10.1016/j.esmoop.2026.108360.
Peer-Reviewed Original Research
Menarche, menopause, reproductive life span and menopause-specific quality of life: a cohort study
Xie Z, Tang R, Huang F, Feng P, Fan Y, Yang X, Huang J, Ma X, Yuan S, Chen R. Menarche, menopause, reproductive life span and menopause-specific quality of life: a cohort study. Climacteric 2026, ahead-of-print: 1-10. PMID: 42565665, DOI: 10.1080/13697137.2026.2702817.
Peer-Reviewed Original Research
Correction: Mutational patterns in a large cohort of parathyroid carcinomas
Pandya C, Uzilov A, Costa-Guda J, Bellizzi J, Taik P, Moe A, Strahl M, van der Tuin K, Stevenson M, Cavaco B, Cetani F, Marcocci C, Karhu A, Arola J, Schalin-Jäntti C, Morreau H, Thakker R, Schadt E, Sebra R, Li S, Chen R, Arnold A. Correction: Mutational patterns in a large cohort of parathyroid carcinomas. Journal Of Endocrinological Investigation 2026, 1-1. PMID: 42560459, DOI: 10.1007/s40618-026-02959-4.
Commentaries, Editorials and Letters
Menopausal arthralgia and longitudinal changes in sex hormones and climacteric symptoms
Xie Z, Tang R, Huang F, Feng P, Fan Y, Yang X, Huang J, Ma X, Yu Q, Yong E, Chen R. Menopausal arthralgia and longitudinal changes in sex hormones and climacteric symptoms. BMC Medicine 2026 DOI: 10.1186/s12916-026-05118-x.
Peer-Reviewed Original Research
Ultrasensitive circulating tumor DNA detection improves prognostication in triple-negative breast cancer postneoadjuvant therapy
Cabel L, Lamy C, Abbott C, Keough K, Pouget N, Pierga J, Sablin M, Flavius J, Bronzini T, Laas E, Darrigues L, Li B, Navarro F, Féron J, Fourchotte V, Bonneau C, Vincent-Salomon A, Boyle S, Chen R, Le Tourneau C, Bidard F. Ultrasensitive circulating tumor DNA detection improves prognostication in triple-negative breast cancer postneoadjuvant therapy. ESMO Open 2026, 11: 108334. PMID: 42531804, PMCID: PMC13452295, DOI: 10.1016/j.esmoop.2026.108334.
Peer-Reviewed Original Research
MeSH Keywords
Single-cell transcriptome analysis in ovarian steroid cell tumors-not otherwise specified
Huang F, Chen H, Mei S, Xue H, Wang Q, Lu Z, Zhang P, Chen R. Single-cell transcriptome analysis in ovarian steroid cell tumors-not otherwise specified. Journal Of Ovarian Research 2026, 19: 241. PMID: 42469914, PMCID: PMC13378070, DOI: 10.1186/s13048-026-02137-3.
Peer-Reviewed Original Research
MeSH Keywords
Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer
Tarantino P, Li T, Ogayo E, Rahman T, DiLullo M, Patel A, El-Refai S, Abbott C, Li B, Boyle S, Chen R, Desai N, Spring L, Tung N, Sinclair N, Faggen M, Constantine M, King T, Krop I, Tayob N, Mittendorf E, Tolaney S, Winer E, Parsons H, Waks A. Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer. JAMA Oncology 2026, 12: 868-874. PMID: 42348190, PMCID: PMC13306490, DOI: 10.1001/jamaoncol.2026.2023.
Peer-Reviewed Original Research
MeSH Keywords
Genetically supported drug target prioritization for rare diseases
Chen R, Duffy Á, Mort M, Cooper D, Rocheleau G, Jordan D, Do R. Genetically supported drug target prioritization for rare diseases. Genome Medicine 2026, 18: 83. PMID: 42277932, PMCID: PMC13255270, DOI: 10.1186/s13073-026-01671-5.
Peer-Reviewed Original Research
MeSH Keywords
Large-Scale Evaluation of Five Large Language Models in Anesthesia Decision-Making for Hip Fracture Surgery.
Chen R, Warburton A, Do R, Chen D, Katz D, Burnett G. Large-Scale Evaluation of Five Large Language Models in Anesthesia Decision-Making for Hip Fracture Surgery. Anesthesia & Analgesia 2026 PMID: 42268736, DOI: 10.1213/ane.0000000000008148.
Peer-Reviewed Original Research

See All Publications

ORCIDs